en

PRODUCT DETAIL

SIRTURO 100 mg tablety

Code 2487C
MA number EU/1/13/901/002
Product Form: tbl 24x100 mg (blis.Al/Al)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU Orphan
MAH, country: Janssen - Cilag International N.V., Belgium
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AK Other drugs for treatment of tuberculosis
J04AK05 Bedaquiline
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 05.03.2014
Validity: 17.06.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.06.2024
eu-flag.png sk-flag.png